Baird downgraded Kohl's (NYSE:KSS) to "neutral" from "outperform" after the company's weak third quarter and noted the ...
周三,金融服务公司Baird将PTC Therapeutics (NASDAQ:PTCT)的股票目标价从此前的48.00美元上调至52.00美元,同时维持"跑赢大市"评级。此次调整是在当天早些时候举行的一场关键意见领袖(KOL)活动之后做出的,该活动聚焦于一种罕见遗传病——弗里德赖希共济失调。 Baird的分析师对该公司的前景表示乐观,特别强调了PTC Therapeutics管线中的药物sepi ...
周二,Baird对Bright Minds Biosciences Inc. (NASDAQ: DRUG)启动了覆盖,给予该股票"跑赢大盘"评级,并设定75.00美元的目标价。这一覆盖始于该公司的主要药物BMB-101(一种5-HT2C激动剂)正在进入第二阶段开发,旨在治疗发育性癫痫性脑病 (DEE)和失神性癫痫。
Baird Equity began coverage of Rambus ( NASDAQ: RMBS) with an Outperform rating and a $90 price target. Shares of the DDR ...
Baird lowered the firm’s price target on Fluence Energy (FLNC) to $24 from $27 and keeps an Outperform rating on the shares.
The pair, who got engaged in June, held their nuptials at a private residence on Sullivan's Island on Saturday, Nov. 23 ...
Unlock the state of the GovCon market with these remarks from Baird Managing Director Jean Stack, as delivered at the 2024 ...
Baird raised the firm’s price target on Gap (GAP) to $29 from $28 and keeps a Neutral rating on the shares. The firm said ...
Investing.com -- In a note to clients Wednesday, Baird downgraded Kohl's Corporation (NYSE: KSS) to Neutral, citing a combination of ongoing challenges and heightened uncertainty. Analysts highlighted ...
Purdue alumnus and U.S. Rep. Jim Baird of Indiana’s 4th Congressional District, which includes the city of West Lafayette, ...